Literature DB >> 18514330

Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs.

E Sanchez-Robert1, L Altet, J Alberola, A Rodriguez-Cortés, A Ojeda, L López-Fuertes, M Timon, A Sanchez, O Francino.   

Abstract

Canine visceral leishmaniasis (CVL) is caused by Leishmania infantum, an intracellular protozoan parasite that causes a severe infectious disease. To evaluate the gene expression profile associated to CVL in vivo, we have measured monthly by real-time PCR over one year the IL-4, IL-10, IL-12, IL-13, IFN-gamma, TGF-beta and TNF-alpha mRNA levels in peripheral blood mononuclear cells in 6 experimentally infected dogs that exhibited different progressions of the illness. While in two dogs no parasite, or a very low number of parasites, was detected and the two dogs did not show any clinico-pathological abnormalities at the end of the study (L dogs), for the remaining dogs high parasite loads were detected and they developed clinical leishmaniasis (H dogs). The L dogs have null expression of both IL-4 and IL-13 for the first 4 months after the infection, whereas an early IL-4 and IL-13 expression occurs in this period of infection in most of the dogs that developed clinical leishmaniasis (H dogs). Furthermore, a higher IFN-gamma expression was associated with the increase of parasite load and clinical status in these dogs. Moreover, the high variability of expression at the pre-infection stage causes us to reject the possibility that the basal levels of these cytokines indicate the prognosis of the subsequent response against infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514330     DOI: 10.1016/j.vetimm.2008.04.010

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Evaluation of TNF-α, IL-4, and IL-10 and parasite density in spleen and liver of L. (L.) chagasi naturally infected dogs.

Authors:  A DE F Michelin; S H V Perri; V M F De Lima
Journal:  Ann Trop Med Parasitol       Date:  2011-07

2.  Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.

Authors:  Dirlei Nico; Carla Claser; Gulnara P Borja-Cabrera; Luiz R Travassos; Marcos Palatnik; Irene da Silva Soares; Mauricio Martins Rodrigues; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2010-11-09

3.  Genetic control of canine leishmaniasis: genome-wide association study and genomic selection analysis.

Authors:  Javier Quilez; Verónica Martínez; John A Woolliams; Armand Sanchez; Ricardo Pong-Wong; Lorna J Kennedy; Rupert J Quinnell; William E R Ollier; Xavier Roura; Lluís Ferrer; Laura Altet; Olga Francino
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

4.  Vaccines for canine leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

5.  Association of Canine Osteosarcoma and Monocyte Phenotype and Chemotactic Function.

Authors:  J L Tuohy; B D X Lascelles; E H Griffith; J E Fogle
Journal:  J Vet Intern Med       Date:  2016-06-23       Impact factor: 3.333

6.  Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.

Authors:  Elisangela Oliveira Freitas; Dirlei Nico; Marcus Vinícius Alves-Silva; Alexandre Morrot; Keith Clinch; Gary B Evans; Peter C Tyler; Vern L Schramm; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2015-12-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.